Cytologic findings of acquired cystic disease‐associated renal cell carcinoma: A report of two cases
Authors:
- 16 April 2008
- journal article
- case report
- Published by Wiley in Diagnostic Cytopathology
- Vol. 36 (5) , 344-347
Abstract
Renal tumors may arise in the setting of end‐stage renal cell disease. The risk is 100 times that of the normal population with an incidence ranging from 3–7%. The most common malignant tumor to arise in the setting of acquired cystic disease of the kidney is the acquired cystic disease‐associated renal cell carcinoma (ACD‐associated RCC). The cytomorphologic features of ACD‐associated RCC, which has not been described previously, show moderately cellular specimens composed of clusters of cells with papillary configuration. The cells ranged from polygonal to columnar and contained abundant eosinophilic granular cytoplasm. The nuclei were round and centrally located, and the chromatin was finely granular with prominent central nucleoli that corresponded to Fuhrman's grade 3 nucleolar size. The main differential diagnosis is type 2 papillary renal cell carcinoma, from which it can be distinguished based on clinical findings only at this moment. Diagn. Cytopathol. 2008;36:344–347.Keywords
This publication has 7 references indexed in Scilit:
- Alpha-methyl CoA racemase expression in renal cell carcinomasHuman Pathology, 2006
- Renal Cell Carcinoma and End Stage Renal DiseaseJournal of Urology, 2006
- Spectrum of Epithelial Neoplasms in End-Stage Renal DiseaseAmerican Journal of Surgical Pathology, 2006
- The Usefulness of Immunohistochemical Markers in the Differential Diagnosis of Renal NeoplasmsClinics In Laboratory Medicine, 2005
- Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: A pathologic analysisKidney International, 2002
- Fine-needle aspiration of the adult kidneyCancer, 1997
- Acquired cystic disease of the end-stage kidneyThe American Journal of Medicine, 1985